With the increasing number of patients diagnosed with hypertension, the annual consumption of sartan drugs has surged, resulting in their ubiquitous detection in aquatic environments. This increases concerns about their environmental persistence and unexpected toxicity. This study explores the applications of ferrate(VI) (Fe(VI)) in removing sartan blood pressure regulators (losartan (LOS), valsartan (VAL), and telmisartan (TEL)). Results demonstrate that sartans could be effectively removed by Fe(VI). Oxidation of LOS by Fe(VI) was pH-dependent at pH 7.0–9.0, with HFeO4– dominating the reaction. The second-order rate constants (kapp) of LOS with Fe(VI) decreased with increasing solution pH, and kapp was calculated to be 148.37 M−1 s−1 at pH 8.0. Furthermore, the Fe(VI)-Fe(III), Fe(VI)-S(IV), and Fe(VI)-S2O32– systems demonstrated the enhancement for the elimination of LOS, while the Fe(VI)–HCO3– system inhibited the reaction. Oxidizing product (OP) analysis suggested that the major transformation patterns of LOS, VAL, and TEL treated by Fe(VI) and its activation systems included oxidation, imidazole ring cleavage, cyclization, N-dealkylation, and bond cleavage. Multiple OPs were estimated to be more persistent and mobile than parent sartans, while their toxicity toward aquatic organisms might be several times lower than those of their parents. Overall, this study elucidates the oxidizing feasibility of Fe(VI) and related activation systems to eliminate sartans in water treatment.
Read full abstract